Dettagli del prodotto
Luogo di origine: Cina
Marca: Sunshine
Certificazione: ISO,COA
Numero di modello: 178306-51-9
Termini di pagamento e di spedizione
Quantità di ordine minimo: Negoziazione
Prezzo: Negoziabile
Imballaggi particolari: Sacchetto di foglio di alluminio, tamburo
Tempi di consegna: 7-15 giorni
Termini di pagamento: T/T, L/C, D/A, Western Union
Capacità di alimentazione: Tonne
CAS NO:: |
178306-51-9 |
Aspetto:: |
solido bianco |
Formula molecolare:: |
C16H16O4 |
Peso molecolare:: |
272.296 |
EINECS NO:: |
605-820-8 |
MDL NO:: |
MFCD13152279 |
CAS NO:: |
178306-51-9 |
Aspetto:: |
solido bianco |
Formula molecolare:: |
C16H16O4 |
Peso molecolare:: |
272.296 |
EINECS NO:: |
605-820-8 |
MDL NO:: |
MFCD13152279 |
Product Description:
Product Name: 2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid CAS 178306-51-9
Synonyms:
hydroxymethoxydiphenylpropanoicacid;
rac-2-hydroxy-3-methoxy-3,3-diphenylpropionic acid;
Chemical & Physical Properties:
Appearance :white solid
Assay :≥99.0%
Density:1.25 g/cm3
Boiling Point: 430.3℃ at 760 mmHg
Flash Point:158.4℃
3-methoxy-2-hydroxy-3,3-diphenylpropionic acid is used to Ambrisentan intermediate.
Anrisentan is a selective endothelin receptor antagonist, which has the effects of reducing endogenous vasoconstriction, antiproliferative and anti-inflammatory. Anrisentan is a specific endothelin receptor A (ETA receptor) inhibitor developed by Gilead Science Company. It is a highly selective ETA receptor antagonist that can block the binding of ET and ETA, thereby blocking ETA-mediated pulmonary vasoconstriction and smooth muscle cell proliferation.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
